doi: 10.1080/0886022x.2024.2327495 81 KimSKangSWJooJHanSHShinHNamBYet al
However, a pharmacovigilance study using the WHO's global adverse drug reaction database found disproportionate reporting of eating disorder adverse events with all three major GLP-1 medications ( Nishida et al., Clinical Nutrition, 2025 )
Excessive use of magnesium, usually as a laxative or antacid, can also cause hypermagnesaemia at intakes over 2500 mg magnesium (elemental)
The side effect profiles of cagrilintide and retatrutide are broadly consistent with other incretin-based therapies, reflecting their shared mechanisms of action
TL;DR: Compounded GLP1s are custom-made medications designed to meet individual patient needs, especially useful during drug shortages or when specific formulations are required
Additionally its also suppressed my appetite considerably